Press Releases

Dyno Therapeutics Launches Dyno eCap 1™ Vector, a Field-Leading AAV Capsid for Eye Gene Therapies

– 80x improvement vs. AAV2 in delivery to the retina seen in non-human primate (NHP) – – Head-to-head against other retina-IVT capsids, Dyno eCap 1 ...
Read More →
Press Releases

Dyno Therapeutics to Present on Breakthrough Optimized AAV Capsids for Eye and CNS Gene Delivery at ESGCT Annual Congress

WATERTOWN, Mass., October 11, 2023 – Dyno Therapeutics, Inc., a techbio company pioneering applications of artificial intelligence to engineering AAV capsids that expand the potential ...
Read More →
Press Releases

Dyno Therapeutics Launches the Dyno bCap 1™ Capsid Product, a Breakthrough CNS Gene Delivery Vector Created with Generative Artificial Intelligence

– Dyno bCap 1 exhibits 100x improvement versus AAV9 in delivery to the central nervous system (CNS) and 10x detargeting of liver after intravenous (IV) ...
Read More →
Press Releases

Dyno Therapeutics to Present New Data on Optimized AAV Capsids with Transformative Therapeutic Delivery Potential at 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

WATERTOWN, Mass., May 2, 2023 – Dyno Therapeutics, Inc., a techbio company pioneering applications of artificial intelligence to engineering AAV capsids that can expand the ...
Read More →
Press Releases

Dyno Therapeutics Named on the Forbes List of America’s Best Startup Employers 2022

BOSTON, MA — March 11, 2022— Dyno Therapeutics is pleased to announce it has been recognized on the Forbes list of America’s Best Startup Employers 2022. ...
Read More →
Press Releases

Dyno Therapeutics Presents State-of-the-Art Applications of Machine Learning to Design Improved AAV Capsids for a Broad Range of Gene Therapies at American Society of Gene and Cell Therapy Conference

Presentations describe use of in vivo screening and machine learning to accelerate the analysis, design, and validation of improved AAV vectors.
Read More →
Press Releases

Dyno Therapeutics Closes $100 Million Series A Financing Led by Andreessen Horowitz to Accelerate AI-powered Gene Therapy Platform

Dyno is making AAV gene therapies more effective, safer, more manufacturable and applicable to more diseases, and will expand capacity to meet partnership demand Cambridge, ...
Read More →
Press Releases

Dyno Therapeutics Announces Presentations at 2021 American Society of Gene and Cell Therapy Annual Meeting (ASGCT)

Company will deliver three oral abstracts and host an Industry Symposium Cambridge, MA – April 27, 2021 – Dyno Therapeutics, a biotechnology company applying artificial ...
Read More →
Press Releases

Dyno Therapeutics Names Dr. Debora Marks and Dr. Nicole Paulk to Scientific Advisory Board

Scientific leaders bring deep expertise in machine learning and AAV gene therapy Cambridge, MA – April 26, 2021 – Dyno Therapeutics, a biotech company applying ...
Read More →
Press Releases

Dyno Therapeutics announces publication in Nature Biotechnology demonstrating use of artificial intelligence to generate unprecedented diversity of AAV capsids and broaden reach of gene therapies

Cambridge, MA – February 11, 2020 – Dyno Therapeutics, a biotech company applying artificial intelligence (AI) to gene therapy, today announced a publication in Nature ...
Read More →
Press Releases

Dyno Therapeutics Enters Collaboration and License Agreement with Roche to Develop Next-Generation AAV Gene Therapy Vectors for CNS Diseases and Liver-Directed Therapies

Collaboration combines Dyno’s AI-powered AAV vector capabilities with Roche and Spark Therapeutics’ leading-edge gene therapy capabilities Dyno is eligible to receive milestone payments that may ...
Read More →
Press Releases

Xconomy names Dyno Therapeutics 2020 Startup of the Year

Dyno Therapeutics has been named Startup of the Year by Xconomy, an award that recognizes the most innovative new company with a focus on those ...
Read More →
Press Releases

Dyno Therapeutics Announces Presentations at 2020 American Society of Gene and Cell Therapy Conference

Dyno sponsors ASGCT virtual career fair  Cambridge, Mass., May 12, 2020 – Dyno Therapeutics, a biotechnology company applying artificial intelligence (AI) to gene therapy, today ...
Read More →
Press Releases

Dyno Therapeutics Announces Ocular Collaboration with Novartis to Develop Improved Gene Therapies with AAV Vectors based on AI Technology

Collaboration focuses on gene therapies for serious eye diseases and leverages Dyno’s CapsidMap™ artificial intelligence platform to design AAV vectors Financial terms include upfront consideration, ...
Read More →
Press Releases

Sarepta Therapeutics and Dyno Therapeutics Announce Agreement to Develop Next-Generation Gene Therapy Vectors for Muscle Diseases

— Agreement leverages Sarepta’s leadership in gene therapy for neuromuscular and cardiovascular diseases and Dyno’s CapsidMap artificial intelligence platform to design AAV vectors —  CAMBRIDGE, ...
Read More →
Back to Top